Jan 18 (Reuters) - MDXHEALTH SA:
* ‍DEVELOPS BLOOD TEST TO GUIDE PRECISION-TREATMENT OF CASTRATION-RESISTANT PROSTATE CANCER PATIENTS​
* STUDY DEMONSTRATES TEST CAN ADD PROGNOSTIC INFORMATION ON OVERALL SURVIVAL
* ‍EARLIER ASSESSMENT OF TREATMENT RESPONSE CAN HELP IDENTIFY RESISTANCE SOONER​
* OVER 233,000 CRPC PATIENTS UNDER TREATMENT GLOBALLY EACH YEAR Source text for Eikon: Further company coverage: (Gdynia Newsroom)
 